ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för SN-38. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

35 träffar

Bibliografisk träff 2021-12-01

Synthesis of novel polymeric nanoparticles (methoxy-polyethylene glycol-chitosan/hyaluronic acid) containing 7-ethyl-10-hydroxycamptothecin for colon cancer therapy: <i>in vitro, ex vivo</i> and <i>in vivo</i> investigation.

Sharifi F, Jahangiri M, Ebrahimnejad P.

Artif Cells Nanomed Biotechnol · journal article · DOI 10.1080/21691401.2021.1907393

Bibliografisk träff 2021-03-16

Image-guided thermosensitive liposomes for focused ultrasound enhanced co-delivery of carboplatin and SN-38 against triple negative breast cancer in mice.

Cressey P, Amrahli M, So PW, Gedroyc W, Wright M, Thanou M.

Biomaterials · research support, non-u.s. gov't; journal article · DOI 10.1016/j.biomaterials.2021.120758

Bibliografisk träff 2021-01-21

Downregulation of breast cancer resistance protein by long-term fractionated radiotherapy sensitizes lung adenocarcinoma to SN-38.

Wang Y, Huang J, Wu Q, Zhang J, Ma Z, Ma S, Zhang S.

Invest New Drugs · research support, non-u.s. gov't; journal article · DOI 10.1007/s10637-020-01003-3

Bibliografisk träff 2020-12-04

Environment-Sensitive Polymeric Micelles Encapsulating SN-38 Potently Suppress Growth of Neuroblastoma Cells Exhibiting Intrinsic and Acquired Drug Resistance.

Polunin Y, Alferiev IS, Brodeur GM, Voronov A, Chorny M.

ACS Pharmacol Transl Sci · research-article; journal article · DOI 10.1021/acsptsci.0c00182

Bibliografisk träff 2020-11-19

Mechanism and optimization of supramolecular complexation-enhanced fluorescence spectroscopy for the determination of SN-38 in plasma and cells.

Zhao K, Guo T, Sun X, Xiong T, Ren X, Wu L, Yang R, Sun H, Shi S, Zhang J.

Luminescence · journal article · DOI 10.1002/bio.3973

Bibliografisk träff 2020-10-29

Development of Self-Associating SN-38-Conjugated Poly(ethylene oxide)-Poly(ester) Micelles for Colorectal Cancer Therapy.

Sadat SMA, Vakili MR, Paiva IM, Weinfeld M, Lavasanifar A.

Pharmaceutics · research-article; journal article · DOI 10.3390/pharmaceutics12111033

Bibliografisk träff 2020-05-08

ABCG2 transports anticancer drugs via a closed-to-open switch.

Orlando BJ, Liao M.

Nat Commun · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s41467-020-16155-2

Bibliografisk träff 2020-05-05

Irinotecan-mediated diarrhea is mainly correlated with intestinal exposure to SN-38: Critical role of gut Ugt.

Sun R, Zhu L, Li L, Song W, Gong X, Qi X, Wang Y, Ghose R, Gao S, Hu M, Liu Z.

Toxicol Appl Pharmacol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.taap.2020.115032

Bibliografisk träff 2020-02-01

Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug.

Wu Z, Li S, Cai Y, Chen F, Chen Y, Luo X.

Colloids Surf B Biointerfaces · journal article · DOI 10.1016/j.colsurfb.2019.110741

Bibliografisk träff 2019-12-23

Co-Prodrugs of 7-Ethyl-10-hydroxycamptothecin and Vorinostat with in Vitro Hydrolysis and Anticancer Effects.

Liu S, Hu Z, Zhang Q, Zhu Q, Chen Y, Lu W.

ACS Omega · research-article; journal article · DOI 10.1021/acsomega.9b02786

Bibliografisk träff 2019-11-09

PLX038: a PEGylated prodrug of SN-38 independent of UGT1A1 activity.

Fontaine SD, Santi AD, Reid R, Smith PC, Ashley GW, Santi DV.

Cancer Chemother Pharmacol · journal article · DOI 10.1007/s00280-019-03987-z

Bibliografisk träff 2019-07-18

Species-specific optimization of PEG~SN-38 prodrug pharmacokinetics and antitumor effects in a triple-negative BRCA1-deficient xenograft.

Fontaine SD, Hann B, Reid R, Ashley GW, Santi DV.

Cancer Chemother Pharmacol · journal article · DOI 10.1007/s00280-019-03903-5

Bibliografisk träff 2018-09-11

Development of a method to quantify total and free irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) for pharmacokinetic and bio-distribution studies after administration of irinotecan liposomal formulation.

Yang W, Yang Z, Liu J, Liu D, Wang Y.

Asian J Pharm Sci · research-article; journal article · DOI 10.1016/j.ajps.2018.08.003

Bibliografisk träff 2016-01-01

PEO-PPO-PEO/Poly(DL-lactide-co-caprolactone) Nanoparticles as Carriers for SN-38: Design, Optimization and Nano-Bio Interface Interactions.

Koliqi R, Dimchevska S, Geskovski N, Petruševski G, Chacorovska M, Pejova B, Hristov DR, Ugarkovic S, Goracinova K.

Curr Drug Deliv · journal article · DOI 10.2174/1567201813666151130221806

Bibliografisk träff 2015-12-04

Langmuir monolayers and Differential Scanning Calorimetry for the study of the interactions between camptothecin drugs and biomembrane models.

Casadó A, Giuffrida MC, Sagristá ML, Castelli F, Pujol M, Alsina MA, Mora M.

Biochim Biophys Acta · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bbamem.2015.12.007

Bibliografisk träff 2015-12-02

The Inhibitory Effect of Ciprofloxacin on the β-Glucuronidase-mediated Deconjugation of the Irinotecan Metabolite SN-38-G.

Kodawara T, Higashi T, Negoro Y, Kamitani Y, Igarashi T, Watanabe K, Tsukamoto H, Yano R, Masada M, Iwasaki H, Nakamura T.

Basic Clin Pharmacol Toxicol · comparative study; journal article · DOI 10.1111/bcpt.12511

Bibliografisk träff 2015-12-02

SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery.

Monterrubio C, Pascual-Pasto G, Cano F, Vila-Ubach M, Manzanares A, Schaiquevich P, Tornero JA, Sosnik A, Mora J, Carcaboso AM.

Biomaterials · research support, non-u.s. gov't; journal article · DOI 10.1016/j.biomaterials.2015.11.055

Bibliografisk träff 2015-11-03

Human Lipocalin-Type Prostaglandin D Synthase-Based Drug Delivery System for Poorly Water-Soluble Anti-Cancer Drug SN-38.

Nakatsuji M, Inoue H, Kohno M, Saito M, Tsuge S, Shimizu S, Ishida A, Ishibashi O, Inui T.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0142206

Bibliografisk träff 2015-11-02

Organic Anion Transporting Polypeptide (OATP)2B1 Contributes to Gastrointestinal Toxicity of Anticancer Drug SN-38, Active Metabolite of Irinotecan Hydrochloride.

Fujita D, Saito Y, Nakanishi T, Tamai I.

Drug Metab Dispos · research support, non-u.s. gov't; journal article · DOI 10.1124/dmd.115.066712

Bibliografisk träff 2015-10-27

Anti-Neoplastic Cytotoxicity of SN-38-Loaded PCL/Gelatin Electrospun Composite Nanofiber Scaffolds against Human Glioblastoma Cells In Vitro.

Zhu X, Ni S, Xia T, Yao Q, Li H, Wang B, Wang J, Li X, Su W.

J Pharm Sci · research support, non-u.s. gov't; journal article · DOI 10.1002/jps.24684

Bibliografisk träff 2015-10-19

Sacituzumab Govitecan, a Novel Antibody--Drug Conjugate, in Patients With Metastatic Platinum-Resistant Urothelial Carcinoma.

Faltas B, Goldenberg DM, Ocean AJ, Govindan SV, Wilhelm F, Sharkey RM, Hajdenberg J, Hodes G, Nanus DM, Tagawa ST.

Clin Genitourin Cancer · clinical trial; journal article · DOI 10.1016/j.clgc.2015.10.002

Bibliografisk träff 2015-09-18

SN-38 active loading in poly(lactic-co-glycolic acid) nanoparticles and assessment of their anticancer properties on COLO-205 human colon adenocarcinoma cells.

Essa S, Daoud J, Lafleur M, Martel S, Tabrizian M.

J Microencapsul · research support, non-u.s. gov't; journal article · DOI 10.3109/02652048.2015.1081416

Bibliografisk träff 2015-09-03

Increased Plasma Concentrations of Unbound SN-38, the Active Metabolite of Irinotecan, in Cancer Patients with Severe Renal Failure.

Fujita K, Masuo Y, Okumura H, Watanabe Y, Suzuki H, Sunakawa Y, Shimada K, Kawara K, Akiyama Y, Kitamura M, Kunishima M, Sasaki Y, Kato Y.

Pharm Res · research support, non-u.s. gov't; journal article · DOI 10.1007/s11095-015-1785-0

Bibliografisk träff 2015-08-31

Convection-enhanced delivery of SN-38-loaded polymeric micelles (NK012) enables consistent distribution of SN-38 and is effective against rodent intracranial brain tumor models.

Zhang R, Saito R, Mano Y, Sumiyoshi A, Kanamori M, Sonoda Y, Kawashima R, Tominaga T.

Drug Deliv · journal article · DOI 10.3109/10717544.2015.1081994

Bibliografisk träff 2015-06-23

Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2-SN-38 Antibody Conjugate (Sacituzumab Govitecan).

Sharkey RM, McBride WJ, Cardillo TM, Govindan SV, Wang Y, Rossi EA, Chang CH, Goldenberg DM.

Clin Cancer Res · journal article · DOI 10.1158/1078-0432.ccr-15-0670

Bibliografisk träff 2015-06-16

Antitumor efficacy and intratumoral distribution of SN-38 from polymeric depots in brain tumor model.

Vejjasilpa K, Nasongkla N, Manaspon C, Larbcharoensub N, Boongird A, Hongeng S, Israsena N.

Exp Biol Med (Maywood) · research support, non-u.s. gov't; research-article; journal article · DOI 10.1177/1535370215590819

Bibliografisk träff 2015-04-28

Inhibition of SN-38 glucuronidation by gefitinib and its metabolite.

Li W, Xing Y, Liu Y.

Cancer Chemother Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1007/s00280-015-2753-4

Bibliografisk träff 2015-04-22

Functional-segregated coumarin-containing telodendrimer nanocarriers for efficient delivery of SN-38 for colon cancer treatment.

Xu G, Shi C, Guo D, Wang L, Ling Y, Han X, Luo J.

Acta Biomater · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.actbio.2015.04.021

Bibliografisk träff 2014-07-02

HPLC analysis and extraction method of SN-38 in brain tumor model after injected by polymeric drug delivery system.

Nittayacharn P, Manaspon C, Hongeng S, Nasongkla N.

Exp Biol Med (Maywood) · research support, non-u.s. gov't; journal article · DOI 10.1177/1535370214539227

Bibliografisk träff 2014-07-01

[Pharmacokinetics of SN-38 in rats and tissue distribution of 7-ethyl-10-hydroxycamptothecin in mice after intravenous injection of irinotecan hydrochloride nanoparticles].

Yang FY, Zhang WP, Wang XY, Yang WC, Dang HW.

Yao Xue Xue Bao · journal article